A new peanut allergy vaccine failed in a trial, but the company wants it approved anyway
An experimental vaccine meant to combat peanut allergy came up short in a large clinical trial, but the company still hopes it can win FDA approval.
by Damian Garde
Oct 20, 2017
1 minute
An experimental vaccine meant to combat peanut allergy came up short on Friday in a large clinical trial, but the company developing it blames the failure on a surprising
You’re reading a preview, subscribe to read more.
Start your free 30 days